The extracellular buildup of amyloid beta (Aβ) plaques in the brain is a hallmark of
Alzheimer's disease (AD). Detection of Aβ pathology is essential for AD diagnosis and for …

Age-associated cerebral small vessel disease (CSVD) represents a clinically heterogenous
condition, arising from diverse microvascular mechanisms. These lead to chronic …

Discovery and development of clinically useful biomarkers for Alzheimer's disease (AD) and
related dementias have been the focus of recent research efforts. While cerebrospinal fluid …

Alzheimer's disease (AD) is a neurodegenerative disease that causes cognitive impairments
in areas such as memory, language, and reasoning. Currently, a definitive diagnosis of AD …

Background Identifying risk factors for Alzheimer disease in women is important as women
compose two-thirds of individuals with Alzheimer disease. Previous work links vasomotor …

Objectives The ATN's different modalities (fluids and neuroimaging) for each of the Aβ (A),
tau (T), and neurodegeneration (N) elements are used for the biological diagnosis of …

Plasma amyloid-β (Aβ) was associated with brain Aβ deposition and Alzheimer's disease
(AD) development. However, changes of plasma Aβ over the course of cognitive decline in …

Alzheimer's disease (AD) is a common cause of dementia, characterised by cerebral
amyloid-β deposition, pathological tau and neurodegeneration. The prodromal stage of AD …

Dementia is a chronic syndrome which is common among the elderly and is associated with
significant morbidity and mortality for patients and their caregivers. Alzheimer's disease …

Accurate differential diagnosis of dementia disorders including Alzheimer's disease (AD),
frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), Parkinson's disease …